Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Project to Combat Food Fraud Wins UK Government Grant

Published: Saturday, February 15, 2014
Last Updated: Saturday, February 15, 2014
Bookmark and Share
Government funding to accelerate the development of a new test to combat food fraud.

Three UK companies have secured government funding to accelerate the development of a new test to combat food fraud in the wake of the horsemeat scandal. The test will detect any DNA in processed foods coming from at least 12 different animal species, including some not normally associated with the food chain. By quantifying the relative amounts of DNA, the test will also indicate the severity of any contamination or deliberate adulteration.

The one-year project is a collaboration between Safeguard Biosystems Holdings Ltd (“SG Bio”), Reading Scientific Services Ltd (“RSSL”) and Arrayjet Ltd (“Arrayjet”). Its potential impact was recognized by the UK’s innovation agency, the Technology Strategy Board, who will co-fund it with the Food Standards Agency and the Department for Food, Environment and Rural Affairs.

Additional funding is provided by the three companies.

This new test is based on proprietary DNA detection technology, developed by the lead partner SG Bio, and will allow identification and quantification of Cow, Pig, Chicken, Horse, Goat, Sheep, Turkey, Donkey, Dog, Cat, Rat and Mouse in foods.

The principle of the test is to identify the targeted DNA sequences in a given food sample and then to calculate the ratio of different species within a sample to establish whether adulteration or contamination has occurred.

The new test aims to reduce the cost and time of food testing so that it becomes possible to routinely check all points in the supply chain. The currently available tests are limited by cost and time. The key to speeding up the process and bringing down costs is making it high-throughput.

It will do this by taking advantage of microarray technology, which enables biological tests to be miniaturized and multiplexed. This allows multiple DNA tests to be carried out on a single sample simultaneously, whilst also enabling multiple food samples to be processed in parallel.

The project has been designed collaboratively utilizing SG Bio’s DNA expertise, Arrayjet’s printing specialization and RSSL’s (a certified food-testing laboratory) expertise in food authenticity.

SG Bio will design and calibrate the test utilizing a reusable DNA SensorArray™ capable of handling 96 separate samples at a time. Once the SensorArray™ design is completed, Arrayjet will be responsible for manufacturing them under tightly regulated conditions.

RSSL will be responsible for extracting DNA from a wide range of raw meat and processed food samples from verified sources and then using these to validate the SensorArray™. For independent corroboration, DNA samples will also be sent to Campden BRI for additional validation.

Expansion of the range of meat species will follow in future versions, as well as the ability to authenticate the breed or location of origin.

Migrating the technology to other food groups that are susceptible to fraud or adulteration such as fish, juices and wine is also planned.

Ultimately the partners would like to see the test used for mass screening by retail chains, regulatory bodies, restaurant and fast food outlets, meat processors and food producers globally to provide consumers with assurance as to what they are buying.

The publication of results is expected in late 2014.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Alan Faichney Joins the Board of Arrayjet as Non-Executive Chairman
Alan has 33 years of commercial and company leadership experience in Technology sector.
Tuesday, September 03, 2013
Arrayjet Continue to Widen Global Sales Channels with New Distribution Deal
Arrayjet appoint Sciencewerke Pte Ltd as a distributor in South East Asia.
Friday, June 07, 2013
Arrayjet Open First US Sales Office
Arrayjet are pleased to announce the relocation of Kelda Rawlings from Edinburgh to North America to manage the opening of a sales office in Cambridge, MA.
Tuesday, August 28, 2012
Arrayjet Widen their Global Sales Channels with Distribution Deal in South Korea
Arrayjet appoint Kyongshin Scientific Co Ltd as Distributor in South Korea.
Monday, June 25, 2012
Arrayjet and Fios Genomics Form Strategic Alliance
Arrayjet Ltd and Fios Genomics announce the formation of a strategic alliance that allows both companies to offer a complete, end to end, microarray solution for their customers.
Monday, November 14, 2011
Generation Scotland and Arrayjet Form Collaboration
The project builds on the complementary strengths of Generation Scotland and Arrayjet to enable the development of new products and services for biomarker identification and development.
Thursday, October 06, 2011
Arrayjet Celebrates Further North American Sales Success
Key installations of four instruments across North America prove growing market need for inkjet microarrayer platform.
Monday, April 20, 2009
Buoyant Market Leads to Rapid Expansion at Arrayjet
Company responds to increasing demand and new applications.
Tuesday, November 27, 2007
Arrayjet Sells two Aj100 Inkjet Microarray Spotters
Two microarray spotters supplied as the mainstay for the Attogram Project.
Wednesday, September 13, 2006
Patent Granted to Arrayjet for Microarray Fabrication
The European patent had been granted for 'Fabrication of microarrays by inkjet printheads'.
Wednesday, December 07, 2005
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Antibiotics on Our Plates 'Could Lead to Health Catastrophe'
Two medical experts from The University of Queensland are urging China to curb its use of antibiotics in animals to avoid what could be a ‘major health catastrophe’ for humans.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos